Clinical Trials Directory

Trials / Completed

CompletedNCT00815269

Vasodilation Effect of Inhalational Anesthetics

Vasodilation Effect of Inhalational Anesthetics Including Halothane, Isoflurane, Sevoflurane, Desflurane and Enflurane

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
300 (actual)
Sponsor
Nanjing Medical University · Academic / Other
Sex
All
Age
19 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Previous studies on animals suggest that inhalational anesthetics can reduce vascular tension in vitro resulting in vasodilation and decrease in blood pressure. This role for inhalational anesthetics has essential clinical implications such as the condition of sepsis or septic shock or other shock-associated states during which the blood vessel constricts strongly and leads to circulation dysfunction. The vasodilation property of these anesthetics including halothane, isoflurane, sevoflurane, desflurane and enflurane enables them to be better options than other general anesthetics in many clinical conditions needing the vasculature to be dilated. The investigators hypothesized that these inhalational anesthetics can evoke vasodilation measured with ultrasonography during general anesthesia in vivo as the in vitro studies displayed.

Conditions

Interventions

TypeNameDescription
DRUGHalothaneInduction: 2-4% halothane pluses 3-5 L/min oxygen Maintenance: different doses from 0.5% to 3% with 1-2 L/min oxygen
DRUGIsofluraneInduction: 2-5% isoflurane pluses 3-5 L/min oxygen Maintenance: different doses from 1% to 4% with 1-2 L/min oxygen
DRUGSevofluraneInduction: 3-8% sevoflurane pluses 3-5 L/min oxygen Maintenance: different doses from 1% to 4% with 1-2 L/min oxygen
DRUGDesfluraneInduction: 2-8% desflurane pluses 3-5 L/min oxygen Maintenance: different doses from 1% to 4% with 1-2 L/min oxygen
DRUGEnfluraneInduction: 2-5% enflurane pluses 3-5 L/min oxygen Maintenance: different doses from 1% to 4% with 1-2 L/min oxygen

Timeline

Start date
2008-12-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2008-12-29
Last updated
2009-12-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00815269. Inclusion in this directory is not an endorsement.